Marion Schuller

Affiliations: 
2018- Oxford University UK 
Google:
"Marion Schuller"
Mean distance: (not calculated yet)
 

Parents

Sign in to add mentor
Stefan Knapp grad student Oxford University UK
Benedikt Kessler grad student 2014-2017 Oxford University UK
 (Investigating strategies to modify PARP14 function through macrodomain inhibition)
Ivan Ahel post-doc 2018- Oxford University UK
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Hloušek-Kasun A, Mikolčević P, Rack JGM, et al. (2022) macrodomain hydrolase SCO6735 cleaves thymidine-linked ADP-ribosylation of DNA. Computational and Structural Biotechnology Journal. 20: 4337-4350
Gahbauer S, Correy GJ, Schuller M, et al. (2022) Structure-based inhibitor optimization for the Nsp3 Macrodomain of SARS-CoV-2. Biorxiv : the Preprint Server For Biology
Schuller M, Ahel I. (2022) Beyond protein modification: the rise of non-canonical ADP-ribosylation. The Biochemical Journal. 479: 463-477
Schuller M, Butler RE, Ariza A, et al. (2021) Molecular basis for DarT ADP-ribosylation of a DNA base. Nature
Bajusz D, Wade WS, Satała G, et al. (2021) Exploring protein hotspots by optimized fragment pharmacophores. Nature Communications. 12: 3201
Schuller M, Correy GJ, Gahbauer S, et al. (2021) Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking. Science Advances. 7
Schuller M, Correy GJ, Gahbauer S, et al. (2020) Fragment Binding to the Nsp3 Macrodomain of SARS-CoV-2 Identified Through Crystallographic Screening and Computational Docking. Biorxiv : the Preprint Server For Biology
Rack JGM, Zorzini V, Zhu Z, et al. (2020) Viral macrodomains: a structural and evolutionary assessment of the pharmacological potential. Open Biology. 10: 200237
Moustakim M, Riedel K, Schuller M, et al. (2018) Discovery of a novel allosteric inhibitor scaffold for polyadenosine-diphosphate-ribose polymerase 14 (PARP14) macrodomain 2. Bioorganic & Medicinal Chemistry
Schuller M, Riedel K, Gibbs-Seymour I, et al. (2017) Discovery of a selective allosteric inhibitor targeting macrodomain 2 of poly-adenosine-diphosphate-ribose polymerases 14. Acs Chemical Biology
See more...